Libo Zou
6PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jun 23, 2020
WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling.Xiaoyu Zhou, Zheng Liu, Ke Ying
|Jul 19, 2019
Protein kinase C is involved in the neuroprotective effect of berberine against intrastriatal injection of quinolinic acid-induced biochemical alteration in mice.Peng Liu, Yinjie Li, Xiaoxiao Qi
|May 04, 2019
Prevention of Huntington's Disease-Like Behavioral Deficits in R6/1 Mouse by Tolfenamic Acid Is Associated with Decreases in Mutant Huntingtin and Oxidative Stress.Peng Liu, Yinjie Li, Wei Yang
|Feb 16, 2019
Xanthoceraside prevented synaptic loss and reversed learning-memory deficits in APP/PS1 transgenic mice.Ge Jin, Lin Zhu, Peng Liu
|Aug 19, 2018
Tolfenamic Acid Attenuates 3-Nitropropionic Acid-Induced Biochemical Alteration in Mice.Peng Liu, Yinjie Li, Danyang Liu
|Nov 11, 2017
Xanthoceraside modulates NR2B-containing NMDA receptors at synapses and rescues learning-memory deficits in APP/PS1 transgenic mice.Lin Zhu, Lei Yang, Xuemei Zhao
Pageof 1
